CY1663A - Cephalosporin salts and injectable compositions - Google Patents

Cephalosporin salts and injectable compositions

Info

Publication number
CY1663A
CY1663A CY1663A CY166393A CY1663A CY 1663 A CY1663 A CY 1663A CY 1663 A CY1663 A CY 1663A CY 166393 A CY166393 A CY 166393A CY 1663 A CY1663 A CY 1663A
Authority
CY
Cyprus
Prior art keywords
injectable compositions
cephalosporin salts
cephalosporin
salts
injectable
Prior art date
Application number
CY1663A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22510643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1663(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1663A publication Critical patent/CY1663A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CY1663A 1988-01-19 1993-05-14 Cephalosporin salts and injectable compositions CY1663A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/144,899 US4910301A (en) 1985-08-05 1988-01-19 Cefepime cephalosporin salts

Publications (1)

Publication Number Publication Date
CY1663A true CY1663A (en) 1993-05-14

Family

ID=22510643

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1663A CY1663A (en) 1988-01-19 1993-05-14 Cephalosporin salts and injectable compositions

Country Status (32)

Country Link
US (1) US4910301A (el)
JP (1) JPH0725768B2 (el)
KR (1) KR950003612B1 (el)
AT (1) AT399878B (el)
AU (1) AU615509B2 (el)
BE (1) BE1002749A5 (el)
CA (1) CA1298288C (el)
CY (1) CY1663A (el)
CZ (1) CZ281602B6 (el)
DD (2) DD284807A5 (el)
DE (1) DE3901359A1 (el)
DK (1) DK162054C (el)
EG (1) EG18749A (el)
ES (1) ES2012948A6 (el)
FI (1) FI86854C (el)
FR (1) FR2626003B1 (el)
GB (1) GB2213819B (el)
GR (1) GR1001218B (el)
HK (1) HK72292A (el)
HU (1) HU205940B (el)
IE (1) IE67447B1 (el)
IT (1) IT1229528B (el)
LU (1) LU87432A1 (el)
NL (1) NL192266C (el)
NZ (1) NZ227605A (el)
OA (1) OA09227A (el)
PT (1) PT89474B (el)
SE (1) SE505258C2 (el)
SG (1) SG75492G (el)
SK (1) SK281768B6 (el)
YU (1) YU221188A (el)
ZA (1) ZA89407B (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
EP0376185B1 (en) * 1988-12-27 1994-08-17 Chugai Seiyaku Kabushiki Kaisha Process for purification of 1,2-bis(nicotinamido)propane
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
US5698703A (en) * 1991-09-10 1997-12-16 Bristol-Myers Squibb Company Syn-isomer of thiazolyl intermediate and process for the preparation thereof
IL103110A (en) * 1991-09-10 1997-04-15 Bristol Myers Squibb Co Anhydrous process for preparing cefepime dihydrochloride hydrate
YU81692A (sh) * 1991-09-10 1995-03-27 Bristol-Myers Co. Postupak za proizvodnju cefalosporinskog antibiotika
US5594129A (en) * 1991-09-10 1997-01-14 Bristol-Myers Squibb Company Process for the preparation of a cephalosporin antibiotic
CA2099692C (en) * 1992-07-24 2003-09-30 Gary M. F. Lim Process for preparing cephalosporin intermediates
US5391729A (en) * 1992-09-08 1995-02-21 Bristol-Myers Squibb Company Crystalline dihydrate of a cephalosporin salt
US5401842A (en) * 1992-09-08 1995-03-28 Bristol-Myers Squibb Company Injectable compositions of a cephalosporin dihydrate salt
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
JPH0840907A (ja) 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤
WO2005094800A2 (en) * 2004-03-31 2005-10-13 Lupin Ltd. A co-precipitated cefepime composition and process for preparation thereof
US20070111980A1 (en) * 2004-07-16 2007-05-17 Bandi Parthasaradhi Reddy Process for preparing pure cephalosporine intermediates
ITMI20051684A1 (it) * 2005-09-13 2007-03-14 Harvest Lodge Ltd Procedimento per la produzione del dicloridrato di amminoacidi
ITMI20060422A1 (it) * 2006-03-09 2007-09-10 Harvest Lodge Ltd Procedimento diretto per la produzione del dicloridrato di un amminoacido
US8151846B2 (en) * 2006-12-15 2012-04-10 Center Line Wheel Corporation Wheel having inner bead-lock
AR077320A1 (es) * 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
CN103304580B (zh) * 2013-06-09 2014-07-09 四川省惠达药业有限公司 一种盐酸头孢吡肟化合物、其制备方法及其药物组合物
WO2017096472A1 (en) * 2015-12-10 2017-06-15 Naeja-Rgm Pharmaceuticals Inc. Cephem compounds, their production and use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
IT1145686B (it) * 1979-05-25 1986-11-05 Glaxo Group Ltd Intermedi per la preparazione di antibiotici cefalosporinici e procedimento per prepararli
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
US4751295A (en) * 1984-04-09 1988-06-14 Bristol-Myers Company Cephalosporin derivatives
US4749694A (en) * 1984-04-26 1988-06-07 Merck & Co., Inc. Novel lysine esters used as absorption
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
US4791196A (en) * 1986-09-26 1988-12-13 Sankyo Company Limited Crystalline cephem carboxylic acid addition salt

Also Published As

Publication number Publication date
SE505258C2 (sv) 1997-07-21
GB8901073D0 (en) 1989-03-15
HUT50347A (en) 1990-01-29
OA09227A (fr) 1992-06-30
DK20789A (da) 1989-07-20
LU87432A1 (fr) 1989-08-30
FI86854C (fi) 1992-10-26
PT89474B (pt) 1993-12-31
JPH0725768B2 (ja) 1995-03-22
NZ227605A (en) 1991-06-25
EG18749A (en) 1993-12-30
SK24389A3 (en) 2000-12-11
ATA8589A (de) 1994-12-15
GR1001218B (el) 1993-06-21
AU2862389A (en) 1989-07-20
CZ24389A3 (en) 1996-08-14
US4910301A (en) 1990-03-20
DK20789D0 (da) 1989-01-18
IT8947539A0 (it) 1988-01-17
ZA89407B (en) 1989-09-27
ES2012948A6 (es) 1990-04-16
DK162054C (da) 1992-02-10
IT1229528B (it) 1991-09-04
KR890011895A (ko) 1989-08-23
CA1298288C (en) 1992-03-31
DD284807A5 (de) 1990-11-28
IE890144L (en) 1989-07-19
SE8900173D0 (sv) 1989-01-18
YU221188A (en) 1990-04-30
SK281768B6 (sk) 2001-07-10
GB2213819A (en) 1989-08-23
GB2213819B (en) 1991-11-27
BE1002749A5 (fr) 1991-05-28
DD283397A5 (de) 1990-10-10
FI890213A (fi) 1989-07-20
FR2626003B1 (fr) 1992-10-16
HU205940B (en) 1992-07-28
JPH029885A (ja) 1990-01-12
DE3901359A1 (de) 1989-10-05
NL192266B (nl) 1996-12-02
FR2626003A1 (fr) 1989-07-21
IE67447B1 (en) 1996-04-03
FI86854B (fi) 1992-07-15
SE8900173L (en) 1989-01-18
HK72292A (en) 1992-10-02
NL8900111A (nl) 1989-08-16
CZ281602B6 (cs) 1996-11-13
FI890213A0 (fi) 1989-01-16
AT399878B (de) 1995-08-25
AU615509B2 (en) 1991-10-03
DK162054B (da) 1991-09-09
SG75492G (en) 1992-10-02
DE3901359C2 (el) 1992-04-30
KR950003612B1 (ko) 1995-04-17
NL192266C (nl) 1997-04-03
PT89474A (pt) 1990-02-08

Similar Documents

Publication Publication Date Title
CY1663A (en) Cephalosporin salts and injectable compositions
NZ224129A (en) Cephalosporin derivatives and pharmaceutical compositions
GB2179936B (en) Cephalosporin salts and injectable compositions
NZ212320A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ222670A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ224130A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ228403A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ225383A (en) Cephalosporin derivatives and pharmaceutical compositions
PH23442A (en) Cephalosporin derivatives and salts thereof
IL88959A (en) Cephalosporin salts and injectable compositions
NZ224997A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ210761A (en) Cephalosporin derivatives and pharmaceutical compositions
ZA852723B (en) Cephalosporin derivatives and salts thereof
IE881066L (en) Cephalosporin derivatives
IE880625L (en) Cephalosporin derivatives
IE882470L (en) Cephalosporin derivatives
GB8914344D0 (en) Compounds and compositions
NZ221951A (en) Substituted cephalosporin derivatives and pharmaceutical compositions
ZA895713B (en) Substituted aminomethyltetralins and their heterocyclic analogues
IE882127L (en) Cephalosporins
IE882093L (en) Cephalosporins
IE881572L (en) Cephalosporins
IE881571L (en) Cephalosporins
IE870886L (en) Injectable composition
IE882497L (en) Cephalosporin derivative